首页> 外国专利> EXPRESSION OF ENDOGENOUS GENES BY NON-HOMOLOGOUS RECOMBINATION OF A VECTOR CONSTRUCT WITH CELLULAR DNA

EXPRESSION OF ENDOGENOUS GENES BY NON-HOMOLOGOUS RECOMBINATION OF A VECTOR CONSTRUCT WITH CELLULAR DNA

机译:向量结构与细胞DNA的非同源重组表达内源基因

摘要

The present invention relates generally to activating gene expression orcausing over-expression of a gene by recombination methods in situ. Theinvention also relates generally to methods for expressing an endogenous genein a cell at levels higher than those normally found in the cell. In oneembodiment of the invention, expression of an endogenous gene is activated orincreased following integration into the cell, by non-homologous orillegitimate recombination, of a regulatory sequence that activates expressionof the gene. In another embodiment, the expression of the endogenous gene maybe further increased by co-integration of one or more amplifiable markers, andselecting for increased copies of the one or more amplifiable markers locatedon the integrated vector. The invention also provides methods for theidentification and expression of genes undiscoverable by current methods sinceno target sequence is necessary for integration. The invention also providesmethods for isolation of nucleic acid molecules (particularly cDNA molecules)encoding transmembrane proteins, and for isolation of cells expressing suchtransmembrane proteins which may be heterologous transmembrane proteins. Theinvention also relates to isolated genes, gene products, nucleic acidmolecules, and compositions comprising such genes, gene products and nucleicacid molecules, that may be used in a variety of therapeutic and diagnosticapplications. Thus, by the present invention, endogenous genes, includingthose associated with human disease and development, may be activated andisolated without prior knowledge of the sequence, structure, function, orexpression profile of the genes.
机译:本发明一般涉及激活基因表达或通过原位重组方法导致基因过表达。的本发明还总体上涉及表达内源基因的方法在一个细胞中的水平高于在细胞中正常发现的水平。合而为一在本发明的一个实施方案中,内源基因的表达被激活或通过非同源或整合进入细胞后增加非法重组,激活表达的调控序列基因的在另一个实施方案中,内源基因的表达可以通过共同整合一种或多种可扩增标记物进一步增加,并且选择一个或多个可扩增标记的增加拷贝数在积分向量上。本发明还提供了用于自从目前的方法无法发现的基因的鉴定和表达整合不需要任何靶序列。本发明还提供分离核酸分子(特别是cDNA分子)的方法编码跨膜蛋白,并分离表达这种蛋白的细胞跨膜蛋白,其可以是异源跨膜蛋白。的本发明还涉及分离的基因,基因产物,核酸分子,以及包含此类基因,基因产物和核酸的组合物酸分子,可用于多种治疗和诊断应用程序。因此,通过本发明,内源基因包括与人类疾病和发展有关的那些可能被激活并无需事先了解序列,结构,功能或基因的表达谱。

著录项

  • 公开/公告号CA2304642C

    专利类型

  • 公开/公告日2014-11-18

    原文格式PDF

  • 申请/专利权人 ATHERSYS INC.;

    申请/专利号CA19982304642

  • 发明设计人 HARRINGTON JOHN J.;

    申请日1998-09-25

  • 分类号C12N15/11;A61K48/00;C12N15/00;C12N15/63;C12N15/67;C12N15/85;C12N15/86;C12N15/90;C12P21/00;

  • 国家 CA

  • 入库时间 2022-08-21 15:11:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号